Continuing Education Activity

Transient global amnesia is a transient neurological syndrome marked by sudden anterograde amnesia with variable retrograde memory loss, typically affecting adults aged 50 to 70 years and lasting 1 to 24 hours. This course reviews the presentation of this condition, characterized by repetitive questioning, preserved self-identity, and absence of focal neurological deficits, and its diagnosis based on clinical criteria, including the Hodges and Warlow criteria, with advanced imaging when atypical features suggest alternative etiologies. Participants will also gain understanding of the pathophysiology, likely involving reversible medial temporal lobe dysfunction, particularly the hippocampus, with proposed links to migraine-related cortical spreading depression and stress-triggered mechanisms. This activity for healthcare professionals is designed to enhance the learner's competence in identifying classic presentations, distinguishing transient global amnesia from stroke, epilepsy, or toxic-metabolic causes, applying evidence-based evaluation strategies, integrating reassurance-based management, avoiding unnecessary testing, counseling regarding its benign prognosis and low recurrence risk, and implementing an appropriate interprofessional approach when managing this condition. 

Objectives:

• Identify the key clinical features of transient global amnesia to support accurate bedside recognition in acute care settings.
• Differentiate transient global amnesia from differential diagnoses using established diagnostic criteria.
• Implement evidence-based management strategies for transient global amnesia.
• Collaborate with an interprofessional team to improve care coordination and outcomes for patients with transient global amnesia.

Access free multiple choice questions on this topic.

Introduction

Transient global amnesia is a clinical syndrome characterized by a sudden onset of temporary profound anterograde amnesia accompanied by variable degrees of retrograde amnesia, typically occurring in adults aged 50 to 70. The amnesic episode typically lasts for several hours, between 1 and 24 hours. Transient global amnesia is not uncommon, especially in emergency medicine practice settings.

Recognizing and characterizing this benign clinical entity with its typical features is essential; no advanced imaging or treatment is required. The clinical picture is typically combined retrograde and anterograde amnesia, with the patient repeatedly asking the same question during the episode. Although disorientation may exist concerning other people and locations, affected patients never lose self-awareness.

Once resolved, the symptoms of transient global amnesia rarely recur. When the patient recovers from the transient global amnesia episode, retrograde amnesia recovers in a telescoping manner, with the most remote memories recovering before more recent ones. The events occurring during the amnesic episode are typically permanently lost. No other neurological deficits are present with this condition. 

The diagnosis of transient global amnesia is mainly clinical. Patients with transient global amnesia do not end up with serious neurological sequelae, including stroke, epilepsy, or neurodegenerative disorders. Any atypical clinical feature should prompt the possibility of an alternative diagnosis, necessitating further diagnostic testing.[1][2][3][4]

Etiology

The etiology of transient global amnesia remains largely unknown, with multiple theories proposed but none conclusively proven. The most supported theory suggests a link to migraines, as 12% to 30% of transient global amnesia patients have a migraine history. Some researchers propose that transient global amnesia may involve cortical spreading depression similar to migraine aura.[5]

Other suspected causes include vascular phenomena, epilepsy, and psychogenic origins. Studies have both supported and refuted arterial ischemia as a cause. Vascular congestion is a leading hypothesis, yet questions about its association with specific age groups and absence in venous thrombosis remain unresolved. Transient global amnesia rarely recurs more than a few times in a patient's life. Ultimately, no single theory fully explains all clinical aspects of transient global amnesia.[6][7][8][9]

Epidemiology

The incidence of transient global amnesia ranges from 3.4 to 10.4 per 100,000 people per year in the general population. In individuals aged 50 or older, this increases to 23.5 to 32 per 100,000 per year, with most cases occurring in those aged 50 to 80. No gender difference has been observed.[10]

Although no clear risk factors have been identified, transient global amnesia is more frequently noted in patients with a history of ischemic heart disease and hyperlipidemia but not with prior ischemic stroke, diabetes, or hypertension. Individuals with migraine have an increased risk, with an incidence risk ratio of 2.48.[10]

Recurrence of transient global amnesia is uncommon but not rare, with rates ranging from 2.9% to 26.3%.[10] Interestingly, transient global amnesia episodes occur more often in the morning between 10 and 11 AM and late afternoon between 5 and 6 PM.[11]

Pathophysiology

The origin of transient global amnesia is believed to involve the mediobasal temporal lobe, particularly the hippocampus, specifically the CA1 (Sommer) sector. These structures are crucial for memory consolidation and retrieval.[5] The hippocampus is especially vulnerable to various metabolic stresses, potentially due to its sensitivity to cytotoxic glutamatergic uptake or release. This selective vulnerability could play an important role in the pathophysiology of transient global amnesia. Affected areas can be unilateral or bilateral, though they are more commonly on the left. Functional magnetic resonance imaging (fMRI) has shown bilaterally reversible deficits; both fMRI and quantitative electroencephalography (qEEG) studies have demonstrated changes in functional connectivity in the hippocampus and limbic system.[12][13][14]

Given the transient and typical clinical features of transient global amnesia during the episode, hypothesizing that the pathophysiology involves transient, reversible dysfunction of the medial temporal lobe, particularly the hippocampus, is reasonable. This theory is supported by the finding of focal diffusion-weighted magnetic resonance imaging (DWI-MRI) changes in patients after their transient global amnesia episode.[15] Recent studies with functional MRI have also demonstrated that transient global amnesia is associated with transient limbic dysconnectivity and selective hypoconnectivity within the mesiotemporal-cingulate episodic memory network.[14] The following are 3 theories for the pathophysiology of transient global amnesia:

• Epileptic mechanism: Focal medial temporal lobe seizures may cause confusion and amnesia. The transient nature also makes the epileptic phenomenon appealing. However, no ictal EEG changes have been documented during transient global amnesia episodes, and recurrences of transient global amnesia are uncommon. The long amnestic episode without any spread of cortical activity and ictal clinical events also argues against an epileptic phenomenon.

• Vascular theory: The old belief was that transient global amnesia may represent transient ischemic attacks, yet this arterial ischemic hypothesis has been disproved due to multiple inconsistencies.[10] Cerebral venous congestion caused by impaired venous drainage from the hippocampus, resulting in congestion and ischemia. Many patients reported Valsalva maneuvers as triggering events for their transient global amnesia. Internal jugular valve incompetence has also been shown to be much more prevalent in patients with transient global amnesia.[16] However, other studies cast further doubt on this mechanism.[17]

• Migraine-related mechanism: This is the most widely believed mechanism. Migraine and transient global amnesia share several features, including the triggers and paroxysmal presentations. The key cortical feature of migraine aura is cortical spreading depression (CSD), a glutamate-mediated transient neuronal depolarization followed by hyperpolarization that spreads along the cortical surface at a speed of 3 to 5 mm/min. Strong emotions or stressful events can trigger the same CSD in humans. Notably, many studies have demonstrated elevated glucocorticoid levels during transient global amnesia episodes and that the density of glucocorticoid receptors in the hippocampus is high. These may explain the relationship between stressful triggers and transient global amnesia episodes, as well as wake-up transient global amnesia episodes.[18]

History and Physical

The diagnosis of transient global amnesia is primarily clinical, based on a detailed history and a thorough neurological examination during the acute stage. Advanced neuroimaging, cerebrospinal fluid analysis, and electroencephalogram (EEG) are unnecessary unless the clinical diagnosis is uncertain. Caplan, Hodges, and Warlow have established diagnostic criteria, and most recently, the German Society of Neurology guidelines.[19][20][21]

Older adult patients tend to have a higher risk of transient global amnesia than young patients. Patients with a diagnosis of migraine have a much higher risk of transient global amnesia compared with nonmigraineurs.[22] Studies also show a higher prevalence of hyperlipidemia, severe hypertension, and ischemic heart disease in transient global amnesia patients. Diabetes and smoking do not have a correlation.[23] Documented transient global amnesia events are associated with a high incidence of precipitating stressful events in 50% to 90% of cases, including emotional stress, physical exertion, Valsalva maneuvers, acute pain, sexual intercourse, or masturbation.[24][25][26]

Patients typically present with a sudden onset of memory loss lasting 4 to 6 hours, nearly always less than 24 hours. Transient global amnesia is characterized by variable retrograde amnesia and pronounced anterograde amnesia. They cannot recall recent events leading up to the episode. They typically ask the same questions repeatedly, eg, "Where are you?" "Why are we here?" No impairment of consciousness is noted, and the patient is fully alert and communicative. Patients retain self-identity and demonstrate no neurological or cognitive deficits. They remain cooperative and can name objects, with no history of trauma or epilepsy. Cognitive examination typically reveals severe impairment in anterograde episodic memory and partial loss of retrograde memory. Executive function may also be impaired. On the other hand, short-term memory (immediate recall), semantic memory, and implicit and procedural memory are spared.[24]

Clinical features making transient global amnesia unlikely include evidence of toxic or metabolic disturbances, a history of trauma or epilepsy, impaired awareness or consciousness, and focal neurological signs. If a patient can describe the episode details and timing, or if they experience more than 3 episodes a year, transient global amnesia should be strongly reconsidered.[21]

The following Hodges and Warlow Criteria are used for transient global amnesia diagnosis:

• The attack is witnessed.
• Clear anterograde amnesia
• No clouding of consciousness, cognitive deficit, or loss of personal identity
• Attack resolves within 24 hours
• No focal neurological signs during or after the attack
• No epileptic features
• No recent head injury or active epilepsy [27][20]

Evaluation

Further evaluation is generally unnecessary when a patient presents to the emergency department with typical clinical features of transient global amnesia. A toxicology screen, alcohol level, and basic laboratory studies, including glucose and electrolytes, are typically performed. Once the amnesic episode resolves, typically within a few hours, the patient can be discharged home.

However, if clinical evidence or routine laboratory studies raise doubts about the diagnosis, the patient should be admitted for monitoring and further diagnostic evaluation. The most important study is brain imaging with MRI. Brain MRI results should be normal during the acute transient global amnesia episode. DWI-MRI lesions, typical for transient global amnesia, most commonly appear 24 to 72 hours after the episode. These are punctate DWI and T2 hyperintensity lesions in 1 or both hippocampi, particularly in the CA1 region.[28]

EEG results are generally normal in patients with transient global amnesia, except for occasional nonspecific theta and delta waves. EEG is useful in differentiating transient global amnesia from amnestic epileptic episodes or transient epileptic amnesia.[29] Cerebrospinal fluid analysis is not indicated unless there is clinical suspicion of an underlying infectious or inflammatory cerebral disorder.

Treatment / Management

Treatment for transient global amnesia primarily involves supportive care and reassurance, as no specific therapy is required or available. A thorough examination is crucial to identify any neurological deficits or signs of head trauma that could suggest an alternative diagnosis. Hospital observation may be necessary until the memory deficit resolves. Intravenous thiamine should be considered. Although rare, recurrences can occur. Following the resolution of memory deficits, patients do not require restrictions on activities (eg, driving).

Differential Diagnosis

In cases where the clinical features of the amnesic episode are unusual, or a focal neurological deficit is noted, excluding acute ischemic stroke affecting the hippocampus (posterior cerebral artery territory infarct) through MRI is crucial. Another significant consideration is transient epileptic amnesia, often observed in patients with a history of focal impaired awareness seizures or epilepsy. These episodes typically last less than an hour and may recur frequently (>3 times per year).

In seizure-related memory loss, seizure-like activity typically precedes the onset, and the memory loss is almost purely retrograde; this differs from transient global amnesia, which involves anterograde amnesia with minimal retrograde amnesia confined to events surrounding the onset. Interictal EEG is the primary diagnostic tool to distinguish between these 2 conditions.[29]

Other important differential diagnoses include the following:

• Basilar artery thrombosis
• Cardioembolic stroke
• Complex partial seizures
• Lacunar syndrome
• Migraine variants
• Posterior cerebral artery stroke
• Syncope
• Temporal lobe epilepsy
• Hypoglycemia
• Wernicke encephalopathy
• Transient ischemic attack
• Toxic encephalopathy
• Hypoxia
• Head injury
• Substance intoxication

These differential diagnoses frequently present with atypical features, often characterized by global confusion rather than the specific memory loss and symptoms typical of transient global amnesia.

Prognosis

Most cases of transient global amnesia occur as isolated events with favorable outcomes and negligible morbidity or mortality reported. Although recurrences are possible, their incidence varies from 2.9% to 26.3% over different follow-up periods, with a 10-year study showing a recurrence rate of 6.3%.[30] A recent study from Korea suggested a potential increased risk of epilepsy following a transient global amnesia episode, with an adjusted hazard ratio of 1.46.[31] However, this finding also underscores the importance of confirming the initial diagnosis of transient global amnesia.

Complications

Complications directly attributable to transient global amnesia are rare, given its typically benign and self-limiting nature. However, the episodic nature of transient global amnesia can lead to significant anxiety and distress for patients and their families during the acute episode. Although uncommon, Recurrence can occur, impacting quality of life and necessitating repeated medical evaluations. In a small subset of cases, some studies have reported that transient global amnesia might be linked to an increased risk of developing epilepsy, highlighting the importance of thorough diagnostic evaluation and follow-up care to monitor for any emerging neurological conditions or sequelae. Despite these considerations, most patients with transient global amnesia experience complete resolution of symptoms without long-term complications or functional impairment.

Consultations

Consultations for patients with transient global amnesia may involve neurologists to confirm the diagnosis and exclude other neurological conditions that may mimic it. Neurologists may recommend brain imaging studies, such as MRI, to rule out acute ischemic stroke or other structural abnormalities. In cases where the diagnosis is uncertain or if atypical features are present, consultations with neuropsychologists or epilepsy specialists may be necessary to perform detailed cognitive assessments or EEG studies to differentiate transient global amnesia from conditions such as transient epileptic amnesia. 

Deterrence and Patient Education

Deterrence and patient education play crucial roles in managing transient global amnesia. Educating patients about the benign nature of transient global amnesia is essential, emphasizing its typically isolated occurrence and favorable prognosis without long-term consequences. Patients should be informed about the importance of seeking medical evaluation during the acute episode to confirm the diagnosis and rule out other potential causes of transient amnesia.

Encouraging lifestyle modifications, eg, stress reduction techniques and adequate management of vascular risk factors, eg, hypertension and hyperlipidemia, may potentially mitigate the risk of recurrent episodes. Furthermore, educating patients to recognize warning signs or symptoms that warrant urgent medical attention, eg, focal neurological deficits or prolonged episodes of confusion, enhances their ability to respond appropriately and seek timely medical care. Empowering patients with accurate information promotes proactive management and ensures optimal outcomes in cases of transient global amnesia.

Pearls and Other Issues

Key clinical pearls can enhance the understanding of transient global amnesia, a fascinating yet often perplexing neurological phenomenon. These pearls help guide clinicians in recognizing, diagnosing, and managing transient global amnesia effectively in clinical practice and include the following:

• Transient global amnesia presents abruptly with a sudden onset of anterograde and retrograde amnesia.

• This disorder predominantly affects adults aged 50 to 80 without gender predilection.

• Transient global amnesia episodes resolve spontaneously within hours without residual cognitive deficits.

• Clinical diagnosis is mainly based on history and examination; neuroimaging and EEG results are generally normal during the acute phase.

• No advanced imaging studies or tests are indicated in these patients.

• Transient global amnesia has an excellent prognosis.

• The differential diagnosis includes acute ischemic stroke involving the hippocampus and transient epileptic amnesia if symptoms recur frequently.

• Episodes may follow vigorous physical activity, emotional stress, or sudden temperature changes.

• Although rare, recurrence rates vary and warrant long-term follow-up and lifestyle modifications.

• Patients should be reassured about the transient nature of symptoms and advised when to seek urgent medical attention if symptoms change or worsen.

• Healthcare professionals must carefully consider alternative diagnoses in atypical presentations or when additional neurological deficits are present to avoid misdiagnosis.

• Neurology consultation should be considered to confirm the diagnosis and guide appropriate management and follow-up care.

Enhancing Healthcare Team Outcomes

Transient global amnesia is a sudden, self-limited syndrome of profound anterograde amnesia with variable retrograde loss, typically lasting 1 to 24 hours in adults aged 50 to 70 years. Patients remain alert, retain self-identity, and frequently exhibit repetitive questioning without focal neurological deficits. Diagnosis is clinical, using established criteria such as those of Hodges and Warlow, with MRI reserved for atypical cases, in which delayed diffusion-weighted imaging may show transient hippocampal lesions. Pathophysiology is thought to involve reversible dysfunction of the medial temporal lobe, particularly the hippocampus, with proposed links to migraine-related cortical spreading depression, vascular congestion, or stress-related mechanisms. Management is primarily supportive, emphasizing reassurance and avoidance of unnecessary testing or hospitalization, as outcomes are typically excellent with rare recurrence.

Interprofessional collaboration enhances diagnostic accuracy and patient safety through coordinated evaluation and management. Physicians and advanced practitioners lead clinical assessment, differentiate transient global amnesia from stroke or seizure, and guide imaging decisions. Neurologists provide diagnostic confirmation in complex cases, while radiologists interpret neuroimaging findings. Nurses support continuous monitoring, patient education, and reassurance during acute episodes. Pharmacists contribute medication safety review and identify potential contributing agents. Primary care clinicians ensure longitudinal follow-up, reinforce education, and address risk factor modification. Structured communication, shared decision-making, and coordinated care pathways reduce misdiagnosis, limit unnecessary interventions, and improve patient-centered outcomes.

The healthcare team must educate caregivers and patients about the benign nature of the disorder. The condition resolves spontaneously and rarely recurs. Patients are advised to maintain a healthy lifestyle, including weight management, smoking cessation, medication adherence, alcohol avoidance, and regular follow-up with their primary care clinician. The outcome in most patients is excellent.[32][33] Transient global amnesia is one of the more perplexing yet benign neurological emergencies. The interprofessional team can enhance patient-centered care, promote favorable outcomes, ensure patient safety, and optimize team performance in managing patients with transient global amnesia.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Alessandro L, Calandri IL, Suarez MF, Heredia ML, Chaves H, Allegri RF, Farez MF. Transient global amnesia: clinical features and prognostic factors suggesting recurrence. Arq Neuropsiquiatr. 2019 Jan;77(1):3-9. [PubMed: 30758436]

2.

Pantoni L. Transient global amnesia: an intriguing yet benign disturbance. Arq Neuropsiquiatr. 2019 Jan;77(1):1-2. [PubMed: 30758435]

3.

Zhang Z, Liu Z, Peng D. Transient Global Amnesia Secondary to Atherosclerotic Stenosis of Accessory Posterior Cerebral Artery. J Stroke Cerebrovasc Dis. 2019 Apr;28(4):e22-e23. [PubMed: 30709618]

4.

Xi S, Martin AJ. Exploring transient global amnesia: a 14-year retrospective study of 142 cases. BMJ Neurol Open. 2026;8(1):e001354. [PMC free article: PMC13007091] [PubMed: 41877735]

5.

Ding X, Peng D. Transient Global Amnesia: An Electrophysiological Disorder Based on Cortical Spreading Depression-Transient Global Amnesia Model. Front Hum Neurosci. 2020;14:602496. [PMC free article: PMC7753037] [PubMed: 33363460]

6.

Völk S, Koedel U, Pfister HW, Schwankhart R, Op den Winkel M, Mühlbauer K, Klein M. Impaired Consciousness in the Emergency Department. Eur Neurol. 2018;80(3-4):179-186. [PubMed: 30541008]

7.

Durrani M, Milas J, Parson G, Pescatore R. Temporary Memory Steal: Transient Global Amnesia Secondary to Nephrolithiasis. Clin Pract Cases Emerg Med. 2018 Nov;2(4):334-337. [PMC free article: PMC6230338] [PubMed: 30443620]

8.

Portaro S, Naro A, Cimino V, Maresca G, Corallo F, Morabito R, Calabrò RS. Risk factors of transient global amnesia: Three case reports. Medicine (Baltimore). 2018 Oct;97(41):e12723. [PMC free article: PMC6203523] [PubMed: 30313071]

9.

Yi M, Sherzai AZ, Ani C, Shavlik D, Ghamsary M, Lazar E, Sherzai D. Strong Association Between Migraine and Transient Global Amnesia: A National Inpatient Sample Analysis. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):43-48. [PubMed: 30305003]

10.

Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N. Transient global amnesia: current perspectives. Neuropsychiatr Dis Treat. 2017;13:2691-2703. [PMC free article: PMC5661450] [PubMed: 29123402]

11.

Hoyer C, Higashida K, Fabbian F, De Giorgi A, Sandikci V, Ebert A, Platten M, Okazaki S, Manfredini R, Szabo K. Chronobiology of transient global amnesia. J Neurol. 2022 Jan;269(1):361-367. [PMC free article: PMC8739464] [PubMed: 34104990]

12.

Hodel J, Leclerc X, Zuber M, Gerber S, Besson P, Marcaud V, Roubeau V, Brasme H, Ganzoui I, Ducreux D, Pruvo JP, Bertoux M, Zins M, Lopes R. Structural Connectivity and Cortical Thickness Alterations in Transient Global Amnesia. AJNR Am J Neuroradiol. 2020 May;41(5):798-803. [PMC free article: PMC7228167] [PubMed: 32381542]

13.

Jung KH, Kang DJ, Lee WJ, Son HS, Kim S, Kang SW. Pathophysiological insight into transient global amnesia from quantitative electroencephalography. Neurobiol Dis. 2022 Aug;170:105778. [PubMed: 35636647]

14.

El Otmani E, Barbeau E, Lemesle B, Milongo-Rigal E, Fernandez S, Charpentier S, Albucher JF, Raposo N, Bonneville F, Péran P, Pariente J. Memory and Resting-State Connectivity in Acute Transient Global Amnesia: A Case-Control fMRI Study. Ann Clin Transl Neurol. 2026 Apr 10; [PubMed: 41958247]

15.

Sparaco M, Pascarella R, Muccio CF, Zedde M. Forgetting the Unforgettable: Transient Global Amnesia Part I: Pathophysiology and Etiology. J Clin Med. 2022 Jun 12;11(12) [PMC free article: PMC9225344] [PubMed: 35743444]

16.

Han K, Hu HH, Chao AC, Chang FC, Chung CP, Hsu HY, Sheng WY, Wu J. Transient Global Amnesia Linked to Impairment of Brain Venous Drainage: An Ultrasound Investigation. Front Neurol. 2019;10:67. [PMC free article: PMC6370701] [PubMed: 30804883]

17.

Kang Y, Kim E, Kim JH, Choi BS, Jung C, Bae YJ, Lee KM, Lee DH. Time of flight MR angiography assessment casts doubt on the association between transient global amnesia and intracranial jugular venous reflux. Eur Radiol. 2015 Mar;25(3):703-9. [PubMed: 25278248]

18.

Schneckenburger R, Hainselin M, Viader F, Eustache F, Quinette P. Serum cortisol levels in patients with a transient global amnesia. Rev Neurol (Paris). 2020 May;176(4):285-288. [PubMed: 31987629]

19.

Caplan LR. Transient global amnesia. What's in a name? J Neurol Sci. 2022 Oct 15;441:120348. [PubMed: 35940029]

20.

Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):834-43. [PMC free article: PMC488242] [PubMed: 2266362]

21.

Sander D, Bartsch T, Connolly F, Enzinger C, Fischer U, Nellessen N, Poppert H, Szabo K, Topka H. Guideline "Transient Global Amnesia (TGA)" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): S1-guideline. Neurol Res Pract. 2023 Apr 20;5(1):15. [PMC free article: PMC10116751] [PubMed: 37076927]

22.

Liampas I, Siouras AS, Siokas V, Tsouris Z, Rikos D, Brotis A, Aloizou AM, Dastamani M, Dardiotis E. Migraine in transient global amnesia: a meta-analysis of observational studies. J Neurol. 2022 Jan;269(1):184-196. [PubMed: 33388926]

23.

Liampas I, Raptopoulou M, Siokas V, Bakirtzis C, Tsouris Z, Aloizou AM, Dastamani M, Brotis A, Bogdanos D, Dardiotis E. Conventional cardiovascular risk factors in Transient Global Amnesia: Systematic review and proposition of a novel hypothesis. Front Neuroendocrinol. 2021 Apr;61:100909. [PubMed: 33539928]

24.

Sparaco M, Pascarella R, Muccio CF, Zedde M. Forgetting the Unforgettable: Transient Global Amnesia Part II: A Clinical Road Map. J Clin Med. 2022 Jul 06;11(14) [PMC free article: PMC9319625] [PubMed: 35887703]

25.

Przepiorka L, Lim J, Lai R, Siddiqui AH, Levy EI. Transient Global Amnesia as a Rare Consequence of Diagnostic Cerebral Angiography at an Ambulatory Neurosurgery Center: A Case Report. Cureus. 2026 Mar;18(3):e105368. [PMC free article: PMC13085505] [PubMed: 42005125]

26.

Bhatti A, Morales Briceno H, Ding P, Wu P, Garber J, Silsby M. Transient global amnesia as a paraneoplastic manifestation of small cell lung cancer. J Neuroimmunol. 2026 Aug;417:578933. [PubMed: 41980526]

27.

Ropper AH. Transient Global Amnesia. N Engl J Med. 2023 Feb 16;388(7):635-640. [PubMed: 36791163]

28.

Lim SJ, Kim M, Suh CH, Kim SY, Shim WH, Kim SJ. Diagnostic Yield of Diffusion-Weighted Brain Magnetic Resonance Imaging in Patients with Transient Global Amnesia: A Systematic Review and Meta-Analysis. Korean J Radiol. 2021 Oct;22(10):1680-1689. [PMC free article: PMC8484159] [PubMed: 34269537]

29.

Butler CR, Graham KS, Hodges JR, Kapur N, Wardlaw JM, Zeman AZ. The syndrome of transient epileptic amnesia. Ann Neurol. 2007 Jun;61(6):587-98. [PubMed: 17444534]

30.

Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, Viader F, Desgranges B, Eustache F. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006 Jul;129(Pt 7):1640-58. [PubMed: 16670178]

31.

Lee SJ, Lee TK, Bae YJ, Kim M. Increased risk of epilepsy after transient global amnesia: A population-based study in South Korea. Clin Neurol Neurosurg. 2024 Aug;243:108357. [PubMed: 38851119]

32.

Sophocles A, Chen L, Lin D, Liu R. Postoperative amnesia in a patient undergoing general anesthesia for electro-physiologic (EP) catheter ablation of an irritable atrial focus. Transl Perioper Pain Med. 2014 Oct 31;1(2):35-38. [PMC free article: PMC4241543] [PubMed: 25429367]

33.

Michel P, Beaud V, Eskandari A, Maeder P, Demonet JF, Eskioglou E. Ischemic Amnesia: Causes and Outcome. Stroke. 2017 Aug;48(8):2270-2273. [PubMed: 28584000]

Disclosure: Forshing Lui declares no relevant financial relationships with ineligible companies.

Disclosure: Benjamin Spurling declares no relevant financial relationships with ineligible companies.